RxDoctor Payments DataLook up a doctor →

Fernando Sanchez, MD

Orthopaedic Surgery · New Orleans, LANPI 1295701035

Payments from drug & device makers

$654,816in general payments, 2019–2025

Across 299 payments — averaging $2190.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medacta USA, Inc.$629K
  • Linkbio Corp$13K
  • DJO, LLC$7K
  • Biocomposites Inc$3K
  • Encore Medical, LP$1K
  • Stryker$212
  • plus $1K from 16 others
$73,468in research payments, 2019–2025

Across 15 payments — averaging $4897.88 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medacta USA, Inc.$73K

What the payments were for

  • Royalty or licence$7710%
  • Consulting fees$423,87588%
  • Speaking & faculty fees$21,5854%
  • Travel & lodging$28,2126%
  • Food & beverage$9,5232%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$654,816 in reported general payments places this provider in the 95th percentile of 286 orthopaedic surgery providers in Louisiana.

See all orthopaedic surgery providers in Louisiana

Medicare billing

Part B allowed, 2024
$62,555
Medicare patients
149
Services billed
355

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Etodolac85$2,658
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen191$1,484
Lidocaine11$1,248
Celecoxib112$757
Ondansetron Hcl96$729
Cephalexin104$602
Mupirocin73$585
Meloxicam158$358
Acetaminophen-CodeineAcetaminophen With Codeine48$349
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav28$331
Hydroxyzine Pamoate82$293
Methylprednisolone45$287
Ciprofloxacin Hcl20$278
Clindamycin Hcl127$267
Tramadol Hcl66$225

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in New Orleans

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →